This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Trovagene, Inc.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Newtown, PA (US) (2014)
- Newton, PA (US) (2016)
Company Filing History:
Years Active: 2014-2016
Title: Innovations by Zhenghan M Xin in HPV Detection
Introduction
Zhenghan M Xin is an accomplished inventor based in Newtown, PA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of high-risk human papillomavirus (HPV). With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
Zhenghan M Xin's latest patents focus on methods for the detection of high-risk HPV. The first patent, titled "Method for detection of high risk human papillomavirus," provides compositions and methods for the differential detection of high-risk forms of HPV from a urine sample provided by a patient. This invention includes primers and probes that specifically recognize and bind sequences within the E1 gene of HPV. The detection of high-risk forms of HPV is crucial for identifying individuals at risk of developing or in the early stages of cervical carcinoma. The second patent, "Genetic marker for detection of human papillomavirus," similarly offers compositions and methods for the differential detection of high-risk forms of HPV from a urine sample. This invention also utilizes primers and probes that specifically recognize and bind sequences within the E gene of HPV, further aiding in the identification of at-risk individuals.
Career Highlights
Zhenghan M Xin is currently associated with Trovagene, Inc., a company focused on developing innovative solutions for cancer detection and monitoring. His work at Trovagene has allowed him to contribute to advancements in molecular diagnostics.
Collaborations
Zhenghan M Xin has collaborated with notable colleagues, including Hovsep S Melkonyan and Samuil R Umansky. These collaborations have fostered a productive environment for innovation and research in the field of HPV detection.
Conclusion
Zhenghan M Xin's contributions to the detection of high-risk HPV through his innovative patents demonstrate his commitment to improving public health. His work continues to pave the way for advancements in medical diagnostics and cancer prevention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile